Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP/GLP-1 receptor agonist that significantly slows gastric emptying
Ready to find the right fit
700 1,500 ( 23,000 50,000 ) : : Wegovy (Semaglutide): 1,349 700 1,000 Saxenda (Liraglutide): 1,300 : : : : (WHO) (WHO issues global guideline on the use of GLP-1 medicines in treating obesity, World Health Organization, 2025) 18,000 50,000 : Wegovy (Semaglutide): 1,349 ( 45,000-50,000 ) 7001,000 ( 18,00025,000 ) Saxenda (Liraglutide): 1,300 ( 43,000-45,000 ) (WHO issues global guideline on the use of GLP-1 medicines in treating obesity, World Health Organization, 2025) : : (WHO) GLP-1 : : (WHO issues global guideline on the use of GLP-1 medicines in treating obesity, World Health Organization, 2025) 1
Unveiling tirzepatides therapeutic spectrum: A dual GIP/GLP-1 agonist targeting metabolic, neurological, and cardiovascular health
Vitamins Vitamins are essential micronutrients that are required in small quantities for a variety of physiological functions in the body, including for those in the brain [12, 92]